Follow
Massimiliano Ruscica
Massimiliano Ruscica
Verified email at unimi.it
Title
Cited by
Cited by
Year
Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4+ T cell metabolic rewiring
V Pucino, M Certo, V Bulusu, D Cucchi, K Goldmann, E Pontarini, R Haas, ...
Cell metabolism 30 (6), 1055-1074. e8, 2019
3142019
Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases
S Ganjali, AM Gotto Jr, M Ruscica, SL Atkin, AE Butler, M Banach, ...
Journal of cellular physiology 233 (12), 9237-9246, 2018
2602018
PPAR agonists and metabolic syndrome: an established role?
M Botta, M Audano, A Sahebkar, CR Sirtori, N Mitro, M Ruscica
International journal of molecular sciences 19 (4), 1197, 2018
2192018
PCSK9 induces a pro-inflammatory response in macrophages
C Ricci, M Ruscica, M Camera, L Rossetti, C Macchi, A Colciago, I Zanotti, ...
Scientific reports 8 (1), 2267, 2018
1922018
Dietary iron overload induces visceral adipose tissue insulin resistance
P Dongiovanni, M Ruscica, R Rametta, S Recalcati, L Steffani, S Gatti, ...
The American journal of pathology 182 (6), 2254-2263, 2013
1732013
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
L Da Dalt, M Ruscica, F Bonacina, G Balzarotti, A Dhyani, E Di Cairano, ...
European heart journal 40 (4), 357-368, 2019
1612019
Liver fat accumulation is associated with circulating PCSK9
M Ruscica, N Ferri, C Macchi, M Meroni, C Lanti, C Ricci, M Maggioni, ...
Annals of medicine 48 (5), 384-391, 2016
1482016
GC–MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect
F Gelmini, G Beretta, C Anselmi, M Centini, P Magni, M Ruscica, ...
International journal of pharmaceutics 440 (2), 170-178, 2013
1292013
Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
M Carratelli, L Porcaro, M Ruscica, E De Simone, AA Bertelli, MM Corsi
International journal of clinical pharmacology research 21 (2), 79-84, 2001
1292001
Molecular aspects of adipokine-bone interactions
P Magni, E Dozio, E Galliera, M Ruscica, MM Corsi
Current molecular medicine 10 (6), 522-532, 2010
1282010
Pharmacokinetics of orally administered melatonin in critically ill patients
G Mistraletti, G Sabbatini, M Taverna, MA Figini, M Umbrello, P Magni, ...
Journal of pineal research 48 (2), 142-147, 2010
1182010
Suppressor of cytokine signaling-3 (SOCS-3) induces proprotein convertase subtilisin kexin type 9 (PCSK9) expression in hepatic HepG2 cell line
M Ruscica, C Ricci, C Macchi, P Magni, R Cristofani, J Liu, A Corsini, ...
Journal of Biological Chemistry 291 (7), 3508-3519, 2016
1172016
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: a consensus statement from the …
JC Fruchart, RD Santos, C Aguilar-Salinas, M Aikawa, K Al Rasadi, ...
Cardiovascular diabetology 18, 1-20, 2019
1162019
The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells
E Dozio, M Ruscica, L Passafaro, G Dogliotti, L Steffani, A Pagani, ...
European journal of pharmacology 641 (1), 29-34, 2010
1152010
Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials
F Fogacci, N Ferri, PP Toth, M Ruscica, A Corsini, AFG Cicero
Drugs 79, 751-766, 2019
1122019
Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin‐sensitivity, lipid profile and …
P Magni, A Liuzzi, M Ruscica, E Dozio, S Ferrario, I Bussi, A Minocci, ...
Clinical endocrinology 62 (2), 189-196, 2005
1042005
Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus
M Ruscica, M Gomaraschi, G Mombelli, C Macchi, R Bosisio, ...
Journal of Clinical Lipidology 8 (1), 61-68, 2014
962014
Risk identification and possible countermeasures for muscle adverse effects during statin therapy
P Magni, C Macchi, B Morlotti, CR Sirtori, M Ruscica
European journal of internal medicine 26 (2), 82-88, 2015
952015
PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement
N Ferri, S Marchianò, G Tibolla, R Baetta, A Dhyani, M Ruscica, P Uboldi, ...
Atherosclerosis 253, 214-224, 2016
942016
The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)
F Zhubi-Bakija, G Bajraktari, I Bytyçi, DP Mikhailidis, MY Henein, ...
Clinical nutrition 40 (1), 255-276, 2021
912021
The system can't perform the operation now. Try again later.
Articles 1–20